Previzion Aksyon Kymera Therapeutics (KYMR)
Dernie pri$112.02Mizajou 25 Sep 2026 19:59 UTC
Chanjman-3.27%
Previzyon AI: KYMR
AI a pibliye yon pri objektif pou pwochen jou trading la, fen semenn nan ak fen mwa nan. Chanjman an mezire depi dènye pri a. Se estimasyon estatistik, se pa konsèy envestisman.
Pri lor dernie 6 mwa
Premium montre bann objektif pri AI pou 1 zour, 1 semenn ek 1 mwa pou sa aksyon la ek pou tou lot aksyon.
Debloke Premium🔒 Historik previzion
Historik previzion an — chak ansyen previzion bò kote klotir reyèl la — fè pati Premium.
Debloke PremiumSou Konpayi Sa a
Kymera Therapeutics, Inc. operates as a biopharmaceutical company focused on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation machinery. Kymera Therapeutics serves customers in Massachusetts.
